Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis pain

Fulranumab, a new class of analgesic therapy, was safe and efficacious in a randomized, double-blind, placebo-controlled trial in patients with moderate to severe osteoarthritis pain.